Evidence map›Paper›PMID 34206186›Full record

ArticleMedicines (Basel, Switzerland)2021

Re-Evaluation of Chemotherapeutic Potential of Pyoktanin Blue.

Hiroshi Sakagami, Toshiko Furukawa, Keitaro Satoh, Shigeru Amano, Yosuke Iijima, Takuro Koshikawa, Daisuke Asai, Kunihiko Fukuchi, Hiromu Takemura, Taisei Kanamoto and 1 more

Open access · goldAbstract read
In one paragraph

Article in Medicines (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Hiroshi SakagamiResearch Institute of Odontology (M-RIO), Meikai University, 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan.ORCID 0000-0001-8001-2121
Toshiko FurukawaDivision of Endodontics and Operative Dentistry, School of Dentistry, Meikai University, 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan.
Keitaro SatohDivision of Pharmacology, Meikai University School of Dentistry, 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan.
Shigeru AmanoResearch Institute of Odontology (M-RIO), Meikai University, 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan.
Yosuke IijimaDepartment of Oral and Maxillofacial Surgery, Saitama Medical Center, Saitama 350-8550, Japan.
Takuro KoshikawaDepartment of Microbiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8511, Japan.
Daisuke AsaiDepartment of Microbiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8511, Japan.ORCID 0000-0003-4015-6694
Kunihiko FukuchiGraduate School of Health Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
Hiromu TakemuraDepartment of Microbiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8511, Japan.
Taisei KanamotoLaboratory of Microbiology, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan.
Satoshi YokoseDivision of Endodontics and Operative Dentistry, School of Dentistry, Meikai University, 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan.
Meikai University · JPSt. Marianna University School of Medicine · JPShowa Pharmaceutical University · JPShowa University · JPSocial Insurance Saitama Chuo Hospital · JP

Funding

Japan Society for the Promotion of Science No. 20K09885
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticancer activityanti-HIVanti-HSVapoptosiscaspase-3chemotherapeutic indexoral cancerpyoktaninsubG1 accumulation

Identifiers

PMID34206186
PMCPMC8305689
OpenAlexW3175911972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.